Skip to main content
TipRanks
Go Ultimate75% OFF

Accendra Health (ACCH) Stock Price & Analysis

570 Followers

ACCH Stock Chart & Stats

$0.02-$0.00(-5.00%)
At close: 4:00 PM EST
$0$0.5$1Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.01 - $0.03
52-Week Range
$0.01 - $4.69
Previous Close
$0.02
Volume
N/A
Average Volume (3M)
4.76M
Market Cap
$1.49M
Enterprise Value
$1.87B
Total Cash (Recent Filing)
$26.61M
Total Debt (Recent Filing)
$1.85B
Price to Earnings (P/E)
―
Beta
1.36
Next Earnings
Feb 24, 2027 (Est.)
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improved Cash Generation

The return to positive operating and free cash flow improves internal funding capacity and provides evidence that stabilization efforts are beginning to convert into cash. However, sustaining this improvement remains important because prior cash generation was volatile and recent operating cash flow is modest relative to business scale.

Liquidity And Debt Management

Substantial available liquidity and covenant compliance give the company room to execute its operational changes and manage near-term obligations. Debt reduction also supports financial flexibility, while the extended receivables facility provides an additional committed funding source through 2029.

Turnaround And Process Modernization

A defined transformation plan addresses several identified commercial and operational bottlenecks rather than relying on a single short-term action. If execution improves referrals, retention, collections, and process efficiency, it could strengthen recurring revenue quality and support more durable profitability.

Bears Say

Negative Stockholders’ Equity

Negative equity indicates a materially weakened capital structure and reduces financial flexibility even though total debt has declined. It can complicate refinancing and credit access, making execution more dependent on reliable cash generation and successful improvement in operating performance.

Revenue Decline And Ongoing Losses

The company has not yet restored durable earnings power: revenue has moved into decline and net profitability remains negative. The improvement from 2025 reduces the severity of losses but does not resolve the underlying challenge of returning to sustained growth and positive margins.

Operational Underperformance And Reduced Outlook

Share losses and weak patient retention, order execution, and collections can pressure both revenue and margins beyond a single quarter. The sharply reduced EBITDA outlook confirms that management expects these operational issues to weigh on near-term results while the turnaround remains unproven.

ACCH FAQ

What was Accendra Health’s price range in the past 12 months?
Accendra Health lowest stock price was $0.01 and its highest was $4.69 in the past 12 months.
What is Accendra Health’s market cap?
Accendra Health’s market cap is $1.49M.
When is Accendra Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Accendra Health overvalued?
According to Wall Street analysts Accendra Health’s price is currently Undervalued.
Does Accendra Health pay dividends?
Accendra Health pays a quarterly dividend of $0.002 which represents an annual dividend yield of ―. See more information on Accendra Health dividends here
What is Accendra Health’s EPS estimate?
Accendra Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Accendra Health have?
Accendra Health has 76,965,324 shares outstanding.
Which hedge fund is a major shareholder of Accendra Health?
Hedge funds hold Accendra Health shares: the largest hedge-fund position in Accendra Health is 72,326,888 shares, and hedge funds increased their holdings by 318.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology